Clinical Trials

NCT07678307 | NOT_YET_RECRUITING | PHASE1/PHASE2
18 participants

A Multicenter, Open-label, Non-randomized, Single-arm Phase 1/2 Study of Autologous Nano CD5-CAR T Cells for the Treatment of Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-01
Start Date:
2026-06-30
Completion:
2027-12-31
Conditions
  • T-Cell Acute Lymphoblastic Leukemia
  • T-Lymphoblastic Lymphoma
  • Relapsed/Refractory Hematologic Malignancies
Interventions
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page